Galecto Announces Clinical Collaboration with Roche for Phase 2 Trial of GB1211 in Combination with Atezolizumab in First Line Non-Small-Cell Lung Cancer

Pat Purcell
Meeting Engagement

Liz Kane
Impactful Strategy

David Linetsky
Point-of-Care Marketing

Frank Burrell
Scientific Storytelling

Matt Turner
Patient Affordability

Bud Bilanich
Success Coach

Paul Theisen
Patient Acquisition

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

Joey Cohen
Medication Adherence

Matthew Durham
Omnidynamic Marketing

Suma Ramadas, PhD
Medical Affairs

Amy Giles
Increasing Engagement

Daniel Sontupe
Market Access